Related Experiment Video
Updated: May 31, 2026
17:42
A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation
Published on: April 13, 2011
Islet transplantation in rodents. Do encapsulated islets really work?
Yngrid Ellyn Dias Maciel de Souza1, Eleazar Chaib, Patricia Graça de de Lacerda
1Universidade Nove de Julho, São Paulo, SP, Brazil.
Arquivos De Gastroenterologia
|June 29, 2011
Summary
Encapsulated islet transplantation shows promise for treating diabetes, with the peritoneal cavity being an optimal implantation site. Further research into microencapsulation strategies is needed for clinical success.
Area of Science:
- Regenerative Medicine
- Transplantation Immunology
- Endocrinology
Background:
- Type 1 diabetes affects millions globally, with high healthcare costs due to complications.
- Pancreatic islet transplantation offers a less invasive alternative to whole pancreas transplantation.
Purpose of the Study:
- To compare encapsulated versus free islet transplantation in rodents.
- To evaluate islet implantation sites, cell number, viability, and immunosuppression needs.
Main Methods:
- A literature review of rodent islet transplantation studies from 2000-2010.
- Analysis of 56 selected articles focusing on encapsulated and non-encapsulated islet transplantation.
Main Results:
- Non-encapsulated islets were primarily implanted in the liver (66%), while encapsulated islets favored the peritoneal cavity (34%).
- The peritoneal cavity offers superior blood supply for islet grafts.
- Strategies like vascular endothelial growth factor enhanced graft vascularization; larger capsules increased necrosis risk.
Conclusions:
- Microencapsulation may eliminate the need for immunosuppression and enable xenotransplantation.
- Optimizing capsule design, donor sources, and implantation sites like the peritoneal cavity are crucial for clinical application.
- Further strategies including genetic engineering and improved oxygen supply are needed to establish islet transplantation as a safe diabetes cure.
